Side-by-side financials for ALLO and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALLO | RVMD |
|---|---|---|
| Market cap | - | $32.71 B |
| US-listed rank | - | #439 |
| Revenue (latest FY) | $0.00 | $0.00 |
| Net income (latest FY) | -$190.89M | -$1.13B |
| SEC filings | 558 | 782 |
In their latest fiscal years, Allogene Therapeutics, Inc. reported $0.00 in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Allogene Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.